Skip to content

Clinical study of minimally invasive surgery for tuberculous empyema based on 3D visualization technology

Clinical study of minimally invasive surgery for tuberculous empyema based on 3D visualization technology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104092
Enrollment
Unknown
Registered
2025-06-11
Start date
2025-06-23
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculous empyema

Interventions

Control group:Conventional open thoracotomy and small-incision thoracoscopic-assisted surgery
Experimental group:Thoracoscopic minimally invasive surgery based on 3D visualization

Sponsors

Beijing Chest Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years, voluntarily participating in the study and signing the informed consent form. 2. Clinically diagnosed with tuberculous empyema. 3. Eligible for thoracoscopic or open thoracic surgery. 4. In the fibrinous stage of tuberculous pleuritis: pleural effusion is compartmentalized or encapsulated, and/or accompanied by thickening of the parietal pleura. 5. In the chronic stage of tuberculous empyema: localized encapsulated empyema with clearly defined boundaries from the lung tissue. 6. No active pulmonary tuberculosis lesions present.

Exclusion criteria

Exclusion criteria: 1. Patients with severe hepatic or renal dysfunction, or a history of psychiatric disorders or epilepsy. 2. Pregnant or breastfeeding women. 3. Patients with active pulmonary tuberculosis. 4. Patients with extensive extrapulmonary tuberculosis. 5. Patients with serious cardiovascular conditions, such as coronary heart disease, or respiratory diseases that severely affect cardiopulmonary function, such as asthma or severe emphysema. 6. Patients with concomitant bronchopleural fistula or empyema with external drainage.

Design outcomes

Primary

MeasureTime frame
Cure rate;Postoperative quality of life;Minimally invasive surgery rate;

Secondary

MeasureTime frame
Operation time;Intraoperative blood loss;Duration of postoperative drainage;Length of hospital stay;Postoperative pain score;

Countries

China

Contacts

Public ContactHan Yi

Beijing Chest Hospital, Capital Medical University

hanyeecn@163.com+86 133 8136 7192

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026